[
  {
    "ts": null,
    "headline": "Hartford Healthcare Fund Q1 2025 Commentary",
    "summary": "The Hartford Healthcare Fund (I Share) underperformed the S&P Composite 1500 Health Care Index during the quarter. Read more here.",
    "url": "https://finnhub.io/api/news?id=1a3e772994eccdb6909ebaf690d19c5d6dc90778298d31e6e0056c9c40e64062",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746715560,
      "headline": "Hartford Healthcare Fund Q1 2025 Commentary",
      "id": 134328189,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1406458240/image_1406458240.jpg?io=getty-c-w1536",
      "related": "ISRG",
      "source": "SeekingAlpha",
      "summary": "The Hartford Healthcare Fund (I Share) underperformed the S&P Composite 1500 Health Care Index during the quarter. Read more here.",
      "url": "https://finnhub.io/api/news?id=1a3e772994eccdb6909ebaf690d19c5d6dc90778298d31e6e0056c9c40e64062"
    }
  },
  {
    "ts": null,
    "headline": "With Competition Rising, Should Investors Give Up On This Top Growth Stock?",
    "summary": "Intuitive Surgical has had little competition for its famous da Vinci system in the U.S.  Intuitive Surgical (NASDAQ: ISRG) has delivered market-crushing returns over the past two decades, thanks to its leadership in the robotic-assisted surgery (RAS) market.  Part of the company's appeal is that its crown jewel has had little competition.",
    "url": "https://finnhub.io/api/news?id=e626c4ae99640891024e7b31a7e6b7badb0f35b8c347e599c2b4bb93129a5e7c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746704700,
      "headline": "With Competition Rising, Should Investors Give Up On This Top Growth Stock?",
      "id": 134325295,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Intuitive Surgical has had little competition for its famous da Vinci system in the U.S.  Intuitive Surgical (NASDAQ: ISRG) has delivered market-crushing returns over the past two decades, thanks to its leadership in the robotic-assisted surgery (RAS) market.  Part of the company's appeal is that its crown jewel has had little competition.",
      "url": "https://finnhub.io/api/news?id=e626c4ae99640891024e7b31a7e6b7badb0f35b8c347e599c2b4bb93129a5e7c"
    }
  }
]